Director of International Affairs
GIP Genopole
Denis is a technology entrepreneur and innovation specialist with over 25 years of achievements, acting in turn as Founder, President-CEO, Executive Chairman, Chairman, Board Director, Counsel, or Seed Investor in over 20 early-stage companies in Canada and in France (e.g., Algene, Nanoledge, Avance Pharma, BioAxone Therapeutics, Evologic, Biobank, Urogene, Cytomics Pharmaceuticals, Planteck Biotechnologies, OncoDiag). Denis was one of the original members of the group of some 300 Founders of King Abdullah University of Science and Technology in Saudi Arabia. In his early career as a research scientist at the University of Quebec and at the Faculty of Medicine of the University of Montreal, Denis’ activities pertained to the establishment of a large multidisciplinary (and inter-institutional) research program on the causes of Alzheimer Disease (Project IMAGE). Denis obtained his Ph.D. in Pharmacology from the University of Cambridge.